National Medical Cannabis Business & Marijuana Legal News

What happened to Women Grow? Rapid growth, strategic changes contributed to contraction

By John Schroyer

In February 2016, Grammy winner Melissa Etheridge delivered a keynote to 1,200 attendees of a leadership summit hosted by Women Grow. The buzz and excitement underscored the organization’s speedy rise to prominence in the marijuana industry, and the future seemed bright.

But less than a year after the summit, Women Grow started to stumble.

Read More

Task force tells AG Sessions to keep status quo for legal cannabis

A task force assembled by Attorney General Jeff Sessions is giving him no ammunition to go after the legal marijuana industry, according to documents obtained by The Associated Press. The Task Force on Crime Reduction and Public Safety has offered no new policy recommendations to advance the attorney general’s aggressively anti-marijuana views. The group’s report largely […]

Read More

DOJ mum on status of marijuana-protecting Cole Memo

Sometimes no news can be good news. And so far, there’s no news from the U.S. Department of Justice on potential policy changes with regard to state marijuana programs, even though July 27 was the deadline for a DOJ task force to submit recommendations on marijuana. National cannabis advocates have been worried that U.S. Attorney General Jeff Sessions […]

Read More

Marijuana companies could soon face major upheaval at federal level

By John Schroyer Life could get a lot harder for the marijuana industry in the next two months, with advocates warning that a pair of cannabis business-protecting federal policies could be in serious jeopardy. At issue is what action the federal government may take involving the precarious 2013 Cole Memo and expiring Rohrabacher-Farr Amendment.

Read More

Coalition sues US government with aim of legalizing cannabis

A group of five diverse plaintiffs have filed suit against the federal government and two Trump administration officials, claiming that marijuana’s status as a Schedule 1 narcotic is unconstitutional and should be changed. The 89-page lawsuit, filed in New York District Court, asks that the Controlled Substances Act of 1970 be declared unconstitutional and that the […]

Read More

DEA slow to move on marijuana research applications

Almost a year after the Drug Enforcement Administration pledged to grant more licenses to grow marijuana for research purposes, the agency has yet to authorize any such applications. The DEA has received at least 25 applications from those interested in growing cannabis for medical research, but none have been approved or rejected, leading some to question […]

Read More

Week in Review: Vermont’s MMJ expansion, cannabis standards & Sessions’ warning

By John Schroyer and Bart Schaneman Vermont adds dispensaries and qualifying conditions to its medical marijuana program, two standards organizations begin work on the cannabis sector, and U.S. Attorney General Jeff Sessions tries to strip MMJ protections. Here’s a closer look at some notable developments in the marijuana industry over the past week.

Read More

Cannabis attorney expects court decision on 280E by ‘end of year’

A potentially game-changing decision by the U.S. Tax Court on the applicability of 280E to the cannabis industry has been delayed, but the attorney who tried the case expects a decision before 2018. Attorney Henry Wykowski argued roughly a year ago before the court that Section 280E of the tax code wasn’t intended to apply to […]

Read More

Ex-Mexico president calls for NAFTA-like international MJ trade

Former Mexican President Vicente Fox called for cannabis to be included in international deals such as the North American Free Trade Agreement (NAFTA). Speaking to reporters Tuesday before delivering a keynote address at the National Cannabis Industry Association conference in Oakland, California, Fox predicted the rise of a legal Mexican marijuana market that will lead […]

Read More

AG Sessions to Congress: Kill medical marijuana protections

U.S. Attorney General Jeff Sessions asked four congressional leaders at the beginning of May to omit key medical marijuana industry protections from a new federal spending bill. Although the attempt was unsuccessful, the letter – first reported by cannabis-focused social media platform MassRoots – underscores that marijuana businesses are not yet totally safe from possible federal […]

Read More